Significant Ownership of Roivant Sciences Ltd.

Signature - Title: /s/ Keyur Parekh - Keyur Parekh, Authorized Signatory
Location: London
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Roivant Sciences Ltd..

Notify me when Roivant Sciences Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Roivant Sciences Ltd.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
IMVT	Immunovant, Inc.	Common Stock, par value $0.0001 per share	55.9%	$2.81B	$414M	113M	+17.2%	Roivant Sciences Ltd.	12 Dec 2025
ABUS	Arbutus Biopharma Corp	Common Shares, without par value	20.5%	$128M		38.8M	0%	Roivant Sciences Ltd.	21 Feb 2025

Schedules 13D/G Reported by Roivant Sciences Ltd.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.